Cytodyn Inc (CYDY)

[Inoviorulez]

Not true in the beginning they make it work.

LJPC was on the OTC and did a reverse stock split from .26 cents per share. Within the first year it went to $20+ per share hit a higher of $45 per share before dropping to where it is now. But it was able to raise cash at higher levels because the stock was at a higher price.

Advaxis did a huge reverse stock split from .04 cents per share. Went to $8 or $12 per share in the short-term then reached $32 per share before falling back down.

The point is that if there is good prospects, which there is for CYDY as it is close to filing a BLA then it can do better than those 2 companies noted above. Because it has already passed a phase 3 study. Those other companies noted above only uplisted while their products were in phase 2...

So to your point reverse splits without a major financing in place at first do not go straight down the toilet. That is false and wrong.